Breakthrough discovery and invention often emerge at the interface between disciplines. For basic discoveries in human biology to have real impact in medicine, engineering developments need to draw on adequate understanding of the biological mechanisms that lead to disease and that determine the action and performance of medicines and therapies. This conference will offer a broad perspective of state-of-the-art approaches leveraging molecular engineering, cellular engineering and materials engineering for the manipulation of the human genome and epigenome, the immune system and diseased tissue, in the contexts of therapy, diagnostics, disease modelling and drug discovery, and across a broad range of disease types. The focus will be on engaging discussions about how to best harness human biology to devise strategies for probing, diagnosing and combating human disease.
- Engineering the immune system
- Engineering mechanics for medicine
- Engineered microenvironments for medicine
- Genome and epigenome engineering
- Engineering microbes for medicine
- Engineered tissues for medicine
Registration fees include:
- All scientific sessions
- Poster sessions
- Meals as indicated in the conference program
- Program book
Cancellations received on or before April 17, 2019 will be honored with a refund minus a $100 administrative fee. Refunds will be credited to the credit card account used for registration. No refunds will be honored for cancellations received after April 17, 2019.
Please submit abstracts by April 1, 2019 at 6:00 p.m.
101 Science Dr.
Durham, NC 27705